NVO vs VRTX: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A S and Vertex Pharmaceuticals Inc in 2026
NVO
Novo Nordisk A S
$37.45
VRTX
Vertex Pharmaceuticals Inc
$474.27
Key Metrics Comparison
| Metric | NVO | VRTX | Winner |
|---|---|---|---|
| Market Cap | $166.46B | $120.46B | NVO |
| P/E Ratio | 10.29 | 30.96 | NVO |
| EPS (TTM) | $3.64 | $15.32 | VRTX |
| Revenue Growth | -0.1% | 0.1% | VRTX |
| Gross Margin | 82.4% | 53.7% | NVO |
Analyze NVO
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NVO or VRTX a better investment?
Comparing NVO and VRTX: Novo Nordisk A S has a market cap of $166.46B while Vertex Pharmaceuticals Inc has $120.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NVO and VRTX?
NVO (Novo Nordisk A S) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NVO or VRTX?
Based on P/E ratios, NVO trades at a lower multiple (10.3x vs 31.0x).
Which is growing faster: NVO or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.1% for NVO.
Which company is more profitable: NVO or VRTX?
Novo Nordisk A S (NVO) has higher gross margins at 82.4% compared to 53.7% for VRTX.
Which is the larger company: NVO or VRTX?
Novo Nordisk A S (NVO) is larger with a market cap of $166.46B compared to $120.46B for VRTX.
Should I buy NVO or VRTX in 2026?
Both NVO and VRTX have investment merit. NVO trades at $37.45 while VRTX trades at $474.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NVO and VRTX stock?
Key differences: Market Cap ($166.46B vs $120.46B), P/E Ratio (10.3x vs 31.0x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (82.4% vs 53.7%).